October 2, 2025LifeOpen Access

Expanding the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus: Impact on Glycemic Control and Metabolic Health

View Full Paper

Ask AI

Bookmark

The use of CGM significantly reduced HbA1c from 8.09 to 7.48 percent and fasting glucose from 152.41 to 137.16 mg/dL.
Results indicated that female patients experienced a greater fasting glucose reduction compared to males.
Paired samples t-tests analyzed outcomes before and after the 12-week CGM intervention in 510 patients.
Findings suggest that considering patient characteristics is crucial for optimizing CGM effectiveness.

Discussion

No takes yet. Share an insight, caveat, or question.

Experiment demonstrates CGM enhances glycemic control in type 2 diabetes patients, highlighting sociodemographic influences.

Lee et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark